Literature DB >> 18593295

The membrane form of tumor necrosis factor is sufficient to mediate partial innate immunity to Francisella tularensis live vaccine strain.

Siobhán C Cowley1, Michael F Goldberg, J Anthony Ho, Karen L Elkins.   

Abstract

Here we characterize Francisella tularensis live vaccine strain (LVS) infection in total tumor necrosis factor (TNF) knockout (KO) mice and in transgenic mice expressing only the membrane form of TNF (memTNF). MemTNF mice, but not TNF KO mice, survived low-dose, sublethal LVS infections. Splenic nitric oxide production was impaired in infected memTNF mice and was absent in infected TNF KO mice. Spleen cell production of interferon-gamma, RANTES, and monocyte chemotactic protein-1 was elevated in TNF KO mice, compared with that in WT mice, by days 4-5 after infection, along with transiently increased numbers of CCR2(+) cells, whereas memTNF mice had an intermediate phenotype. By day 6 after infection, TNF KO mice, but not memTNF mice, exhibited massive apoptosis in spleens and livers, which shortly preceded their death. Thus, memTNF partially functions to regulate chemokine expression, cell recruitment, and nitric oxide production during primary LVS infection and protects against the induction of apoptosis observed in TNF KO mice.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18593295     DOI: 10.1086/589620

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Galantamine effect on tularemia pathogenesis in a BALB/c mouse model.

Authors:  Miroslav Pohanka; Oto Pavlis; Jiri Pikula
Journal:  Iran Biomed J       Date:  2012

2.  Mast cell TLR2 signaling is crucial for effective killing of Francisella tularensis.

Authors:  Annette R Rodriguez; Jieh-Juen Yu; M Neal Guentzel; Christopher S Navara; Karl E Klose; Thomas G Forsthuber; James P Chambers; Michael T Berton; Bernard P Arulanandam
Journal:  J Immunol       Date:  2012-04-23       Impact factor: 5.422

3.  Successful protection against tularemia in C57BL/6 mice is correlated with expansion of Francisella tularensis-specific effector T cells.

Authors:  Amanda J Griffin; Deborah D Crane; Tara D Wehrly; Catharine M Bosio
Journal:  Clin Vaccine Immunol       Date:  2014-11-19

4.  Host immune response and acute disease in a zebrafish model of Francisella pathogenesis.

Authors:  Lucia N Vojtech; George E Sanders; Carla Conway; Vaughn Ostland; John D Hansen
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

5.  Epitope-based vaccination against pneumonic tularemia.

Authors:  Stephen H Gregory; Stephanie Mott; Jennifer Phung; Jinhee Lee; Leonard Moise; Julie A McMurry; William Martin; Anne S De Groot
Journal:  Vaccine       Date:  2009-07-17       Impact factor: 3.641

6.  Development of a murine mycobacterial growth inhibition assay for evaluating vaccines against Mycobacterium tuberculosis.

Authors:  Marcela Parra; Amy L Yang; JaeHyun Lim; Kristopher Kolibab; Steven Derrick; Nathalie Cadieux; Liyanage P Perera; William R Jacobs; Michael Brennan; Sheldon L Morris
Journal:  Clin Vaccine Immunol       Date:  2009-05-20

Review 7.  Differential Immune Response Following Intranasal and Intradermal Infection with Francisella tularensis: Implications for Vaccine Development.

Authors:  McKayla J Nicol; David R Williamson; David E Place; Girish S Kirimanjeswara
Journal:  Microorganisms       Date:  2021-04-30

8.  Immunity to Francisella.

Authors:  Siobhán C Cowley; Karen L Elkins
Journal:  Front Microbiol       Date:  2011-02-16       Impact factor: 5.640

9.  Membrane-bound TNF induces protective immune responses to M. bovis BCG infection: regulation of memTNF and TNF receptors comparing two memTNF molecules.

Authors:  Maria L Olleros; Dominique Vesin; Ruth Bisig; Marie-Laure Santiago-Raber; Sonia Schuepbach-Mallepell; George Kollias; Olivier Gaide; Irene Garcia
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

10.  An Immature Myeloid/Myeloid-Suppressor Cell Response Associated with Necrotizing Inflammation Mediates Lethal Pulmonary Tularemia.

Authors:  Sivakumar Periasamy; Dorina Avram; Amanda McCabe; Katherine C MacNamara; Timothy J Sellati; Jonathan A Harton
Journal:  PLoS Pathog       Date:  2016-03-25       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.